← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Transgenex Nanobiotech, Inc.
Tampa, FL
$3,058,219
Total funding
9
Grants
Funding over time
peak $1.5M · FY2008–17$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$3,058,219 · 9
By mechanism
N44$1,475,002 · 1
N43$974,990 · 4
R41$426,745 · 3
R43$181,482 · 1
Investigators at Transgenex Nanobiotech, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
IGF::OT::IGF: SBIR Phase II, Topic 326: Development of Novel Therapeutic Agents that Target Cancer$1,475,002
N44 · FY2017 · CA
FIBROUS SCAFFOLD-INDUCED SPHEROIDS MIMICKING TME$299,992
N43 · FY2013 · CA
IGF::OT::IGF TRANSGENEX NANOBIOTECH INC:1186317 [15-068310]$225,000
N43 · FY2015 · CA
Biopsy-derived tumoroid platform for personalizing cancer treatment$224,999
N43 · FY2014 · CA
ANTI- NPRA INHIBITORS TARGETING CANCER STEM CELLS IN TUMOROIDS$224,999
N43 · FY2014 · CA
Targeted Delivery of siRNA Nanoparticles to Prevent HIV-1 Transmission$181,482
R43 · FY2008 · AI
Targeting of Curcumin-genistein nanocomplexes for Treatment of Prostate Cancer$158,829
R41 · FY2009 · CA
Chlipoplex Nanoparticle Prophylactics for RSV Infection$157,893
R41 · FY2004 · HL
Chliposome IFN-gamma-pDNA Naoparticle Therapy for Asthma$110,023
R41 · FY2004 · HL